BEAS-2B or A549 cells were transfected with Myc or Myc-Pellino-1 expression plasmids. At 48 hours after transfection, cells were harvested and subjected to immunoblotting with indicates antibodies. B. A549 cells were transfected with Myc or Myc-Pellino-1 expression plasmids and harvested at 48 hours of transfection. The cell lysates were obtained separately from cytoplasmic (Cyto) and nuclear (Nuc) fractions and subjected to immunoblotting with anti-Rel-B, anti-p52, anti-p50, anti-p65, anti-Pellino-1, and anti-actin (as control cytoplasmic fraction) or lamin B1 (as a control for nuclear fraction) antibodies.
) and twelve lung cancer cell lines (A549, Calu-3, Calu-6, H322, H358, H441, H460, H1299, H1264, HCC1833, H1838, H1975; all adenocarcinoma except for H460, large cell carcinoma) were harvested and subjected to immunoblotting for Pellino-1 and indicated TLRs. B and C. A549, H441 and H1975 cells were treated with TLRs agonist against TRL1/2 (Pam3CSK4, 50 ng/ml), TLR2 (HKLM, 10 7 cells/ ml), TLR3 (Poly (I:C), 5 ug/ml), TLR4 (lipopolysaccharide (LPS), 5 ug/ml), TLR5 (ST-FLA, 5 ug/ml), TLR6/2 (lipopeptide FSL-1 (FSL-1), 100 ng/ml) or TLR8 (ssRNA40, 5 ug/ml) for 36 hours. Cells were harvested and subjected to immunoblotting with anti-Pellino-1 and anti-HSP60 (loading control) antibodies (B). Pellino-1 protein expression was quantitated using Image J software as normalized to HSP60 level. Histograms represent relative Pellino-1 protein level in TLRs treated cells compared to DMSO treated cells. Results are represented of three independent experiments (C). D. A549 cells were stimulated with 5 ug/ml Poly (I:C), 5 ug/ml LPS, or 5 ug/ml ssRNA40 at days 0, 2, 4 and 6. At 7 days, cells incubated with crystal violet coloration. Intensity of crystal violet was then determined by spectrometry at 570 nm. DMSO was used as control. All P values were calculated using unpaired Student's t test. *,P <0.05; **, P <0.01; ***, P <0.005.
